Updated employee announcements, business news, awards, and recognition in the industry today.
Elligo Health Research, a clinical research infrastructure provider of clinical research infrastructure (CRI) services and technologies, has hired Deirdre BeVard as chief operating officer.
Clinipace Worldwide, a global full-service CRO, has named industry veteran Steve Skolsky to its Board of Directors. Steve holds 30 years of experience in the pharma, biotech, CRO, and health care services sectors.
Karolinska Development's portfolio company Modus Therapeutics AB, a Nordic life sciences investment company, has recruited Professor Thomas Knittel as its new Chief Medical Officer. Thomas brings along 10 years of clinical and over 15 years of experience from research and development, medical affairs, and marketing within the pharmaceutical industry.
Cmed announced its one-year anniversary of the launch of encapsia, an innovative cloud-based clinical data suite of apps that helps biotech and pharma sponsors transform the way data is captured, monitored, and reviewed in clinical trials.
OmniComm Systems, Inc., a global provider of clinical data management technology, announced that it has received certification approval from the U.S. Department of Commerce for the EU-U.S. Privacy Shield Framework program and the Swiss-U.S. Privacy Shield Framework, the successors to the U.S.-EU and U.S.-Swiss Safe Harbor Frameworks.
Clintec, a global full service CRO, has been presented with the Queens Award for Enterprise 2017, in the
Clintec receives Queens Award for Enterprise 2017
category of International Trade, the highest business accolade that can be granted to any business operating within the UK.
Forte, an industry developer of clinical research solutions, announced the launch of its new brand identity and redesigned website, ForteResearch.com. The new website launch represents their vision for the future as a company.
Certara, a global company in model-informed drug development and regulatory science, announced that Kyowa Hakko Kirin has joined the Simcyp Consortium and licensed the Simcyp Population-based Simulator. They are the 36th biopharmaceutical and 11th Japanese pharmaceutical company to join the Consortium.